{"id":755119,"date":"2023-05-04T15:57:44","date_gmt":"2023-05-04T19:57:44","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/alert-the-ma-class-action-firm-continues-investigating-the-merger-stsa-mybf-trtn-chra\/"},"modified":"2023-05-04T15:57:44","modified_gmt":"2023-05-04T19:57:44","slug":"alert-the-ma-class-action-firm-continues-investigating-the-merger-stsa-mybf-trtn-chra","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/alert-the-ma-class-action-firm-continues-investigating-the-merger-stsa-mybf-trtn-chra\/","title":{"rendered":"ALERT: The M&amp;A Class Action Firm Continues Investigating the Merger \u2013 STSA, MYBF, TRTN, CHRA"},"content":{"rendered":"<div class=\"mw_release\">\n<p>NEW YORK, May  04, 2023  (GLOBE NEWSWIRE) &#8212; <\/p>\n<p>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=6ZXDVk9IdKOJtZCfZZUmDete40_kT9a_Dh39dlIqew9_LlLigNUCGKGP78gJKmRl_XpQ_DGOEp8tlEUs6xY9iIodKweJ2RjFO-XpwuQ8MWw=\" rel=\"nofollow noopener\" target=\"_blank\">Juan Monteverde<\/a>, founder and managing partner of the class action firm <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=aqVEyDQK0A54CT03SmzipJkfJvh2uumNPdTZXJ8ERfBVYgceLbOGtqRRdPBqXAMndiPkA0ab1bBwOrGRbebU_6S-FT9RixElURuFgtX9wSA=\" rel=\"nofollow noopener\" target=\"_blank\">Monteverde &amp; Associates PC<\/a> (the \u201cM&amp;A Class Action Firm\u201d), a national securities firm rated\u00a0<strong>Top 50\u00a0<\/strong>in the 2018-2021 ISS Securities Class Action Services Report and headquartered at the\u00a0<strong>Empire State Building<\/strong>\u00a0in New York City, is investigating:<\/p>\n<ul type=\"disc\">\n<li>\n          <strong>Satsuma Pharmaceuticals, Inc. (NASDAQ: <\/strong><br \/>\n          <a href=\"https:\/\/finance.yahoo.com\/quote\/STSA\" rel=\"nofollow noopener\" target=\"_blank\"><br \/>\n            <strong>STSA<\/strong><br \/>\n          <\/a><br \/>\n          <strong>)<\/strong>, relating to its proposed sale to Shin Nippon Biomedical Laboratories, Ltd. Under the terms of the agreement, STSA Shareholders are expected to receive one non-tradeable CVR of up to $5.77 in cash plus $0.91 in cash per share they own. <strong>Click here for more information: <\/strong><a href=\"https:\/\/www.monteverdelaw.com\/case\/satsuma-pharmaceuticals-inc\" rel=\"nofollow noopener\" target=\"_blank\"><strong>https:\/\/www.monteverdelaw.com\/case\/satsuma-pharmaceuticals-inc<\/strong><\/a><strong>. It is free and there is no cost or obligation to you.<\/strong><\/li>\n<\/ul>\n<ul type=\"disc\">\n<li>\n          <strong>Muncy Bank Financial, Inc. (OTC: <\/strong><br \/>\n          <a href=\"https:\/\/finance.yahoo.com\/quote\/MYBF\" rel=\"nofollow noopener\" target=\"_blank\"><br \/>\n            <strong>MYBF<\/strong><br \/>\n          <\/a><br \/>\n          <strong>)<\/strong>, relating to its proposed acquisition by CCFNB Bancorp, Inc. Under the terms of the agreement, MYBF shareholders are expected to receive 0.9259 shares of CCFNB per share they own. <strong>Click here for more information: <\/strong><a href=\"https:\/\/www.monteverdelaw.com\/case\/muncy-bank-financial-inc\" rel=\"nofollow noopener\" target=\"_blank\"><strong>https:\/\/www.monteverdelaw.com\/case\/muncy-bank-financial-inc<\/strong><\/a><strong>. It is free and there is no cost or obligation to you.<\/strong><\/li>\n<\/ul>\n<ul type=\"disc\">\n<li>\n          <strong>Triton International Ltd. (NYSE: <\/strong><br \/>\n          <a href=\"https:\/\/finance.yahoo.com\/quote\/TRTN\" rel=\"nofollow noopener\" target=\"_blank\"><br \/>\n            <strong>TRTN<\/strong><br \/>\n          <\/a><br \/>\n          <strong>)<\/strong>, relating to its proposed sale to Brookfield Infrastructure Partners, L.P. <strong>Click here for more information: <\/strong><a href=\"https:\/\/www.monteverdelaw.com\/case\/triton-international-ltd\" rel=\"nofollow noopener\" target=\"_blank\"><strong>https:\/\/www.monteverdelaw.com\/case\/triton-international-ltd<\/strong><\/a><strong>. It is free and there is no cost or obligation to you.<\/strong><\/li>\n<\/ul>\n<ul type=\"disc\">\n<li>\n          <strong>Charah Solutions, Inc. (OTC: <\/strong><br \/>\n          <a href=\"https:\/\/finance.yahoo.com\/quote\/CHRA\" rel=\"nofollow noopener\" target=\"_blank\"><br \/>\n            <strong>CHRA<\/strong><br \/>\n          <\/a><br \/>\n          <strong>)<\/strong>, relating to its proposed sale to SER Capital Partners\/ Under the terms of the agreement, CHRA shareholders are expected to receive $6.00 in cash per share they own. <strong>Click here for more information: <\/strong><a href=\"https:\/\/www.monteverdelaw.com\/case\/charah-solutions-inc\" rel=\"nofollow noopener\" target=\"_blank\"><strong>https:\/\/www.monteverdelaw.com\/case\/charah-solutions-inc<\/strong><\/a><strong>. It is free and there is no cost or obligation to you.<\/strong><\/li>\n<\/ul>\n<p>\n        <strong>About Monteverde &amp; Associates PC<\/strong>\n      <\/p>\n<p>We are a national class action securities and consumer litigation law firm <strong>that has recovered millions of dollars <\/strong>for shareholders and <strong>is<\/strong><strong>committed to protecting investors<\/strong> and consumers from corporate wrongdoing.\u00a0Monteverde &amp; Associates lawyers have significant experience litigating Mergers &amp; Acquisitions and Securities Class Actions, whereby they protect investors by recovering money and remedying corporate misconduct. Mr. Monteverde, who leads the firm, has been recognized by Super Lawyers as a Rising Star in Securities Litigation in 2013 and 2017-2019, an award given to less than 2.5% of attorneys in a particular field. He has also been selected by Martindale-Hubbell as a 2017-2020 Top Rated Lawyer. Our firm\u2019s recent successes include changing the law in a significant victory that lowered the standard of liability under Section 14(e) of the Exchange Act in the Ninth Circuit. Thereafter, our firm successfully preserved this victory by obtaining dismissal of a writ of certiorari as improvidently granted at the United States Supreme Court.<em>\u00a0Emulex Corp. v. Varjabedian<\/em>, 139 S. Ct. 1407 (2019). Also, over the years the firm has recovered or secured over a dozen cash common funds for shareholders in mergers &amp; acquisitions class action cases.<\/p>\n<p>If you own common stock in any of the above listed companies and wish to obtain additional information and protect your investments free of charge, please visit our <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=9KcjYjdq31caZA2P3O-rIxrybsdNgdK1PhMhMwWRl_ZREyg-xxGD8nyRjfxeB5Bo0adIpK9c5GbeGh1mvyp0pPfE2i-Zp5G5Oxv0yirb8hjU5GmkMWNKSf-6UAGQjQeoP9j8GQS3cJHaR7KBgLfpeRtUJH30tE_Vkkmv5VPkkR-vil_DGwhf7y8oJ8GnRbiq\" rel=\"nofollow noopener\" target=\"_blank\"><strong><u>website<\/u><\/strong><\/a> or contact Juan E. Monteverde, Esq. either via e-mail at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=RhKcOmKf_nCa3ptIR9DYi1j9Yxm2dm3lWnYwmv2RMpk24LnjUZ6fXP3AnvUeNLXP6HlDo9bN7mG-oWJf0zWNmclGWtalGI_g-Uk0GLSaNSoB8v5sdsIbOqye1PMOf55w\" rel=\"nofollow noopener\" target=\"_blank\"><strong><u>jmonteverde@monteverdelaw.com<\/u><\/strong><\/a> or by telephone at (212) 971-1341.<\/p>\n<p>Contact:<br \/>Juan E. Monteverde, Esq.<br \/>MONTEVERDE &amp; ASSOCIATES PC<br \/><strong>The Empire State Building<\/strong><br \/>350 Fifth Ave. Suite 4405<br \/>New York, NY 10118<br \/>United States of America<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=RhKcOmKf_nCa3ptIR9DYi1j9Yxm2dm3lWnYwmv2RMpmmXYOPH5b0sXfUbNIuDeyxqWlisaRv5SWsRduOEsV11EL7d0Ji33BSZ9nIshiu9CIoj9C84931sMYooAP5oS-5\" rel=\"nofollow noopener\" target=\"_blank\"><u>jmonteverde@monteverdelaw.com<\/u><\/a><br \/>Tel: (212) 971-1341<\/p>\n<p>Attorney Advertising. (C) 2023 Monteverde &amp; Associates PC.\u00a0The law firm responsible for this advertisement is Monteverde &amp; Associates PC (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=eeuQIG6UzUZSy5DKuz1vCLGSkk5W4jptFHJshY7un8pEvu7og3nA_GMDJjHuryfB8tWyAfS1GI5keXo8NuDydDG_BRr5vHN5gaVmFBlm4BwJFnrbEFL5zOKs_uWRP2yS-TN7oupGLsyfusbH2ZeJ8V3UAlg1BLhT5ybwIGJ50Ep0BCUtFTZGqKVsJzqP62spr4ocS12GuIhQ0MqCRmSg-U_PLwDSCzrkAd0-vUgMeXs=\" rel=\"nofollow noopener\" target=\"_blank\"><u>www.monteverdelaw.com<\/u><\/a>).\u00a0 Prior results do not guarantee a similar outcome with respect to any future matter.<\/p>\n<\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMjU1MCM1NTc2Njk3IzIxODQzNTk=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/MTk5MGViZjgtY2EwOC00ZmY2LThkYjQtYzJhZWZmNzM5OWUwLTExOTU5MTM=\/tiny\/Monteverde-Associates-PC.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK, May 04, 2023 (GLOBE NEWSWIRE) &#8212; Juan Monteverde, founder and managing partner of the class action firm Monteverde &amp; Associates PC (the \u201cM&amp;A Class Action Firm\u201d), a national securities firm rated\u00a0Top 50\u00a0in the 2018-2021 ISS Securities Class Action Services Report and headquartered at the\u00a0Empire State Building\u00a0in New York City, is investigating: Satsuma Pharmaceuticals, Inc. (NASDAQ: STSA ), relating to its proposed sale to Shin Nippon Biomedical Laboratories, Ltd. Under the terms of the agreement, STSA Shareholders are expected to receive one non-tradeable CVR of up to $5.77 in cash plus $0.91 in cash per share they own. Click here for more information: https:\/\/www.monteverdelaw.com\/case\/satsuma-pharmaceuticals-inc. It is free and there is no cost or obligation to you. Muncy Bank Financial, &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/alert-the-ma-class-action-firm-continues-investigating-the-merger-stsa-mybf-trtn-chra\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;ALERT: The M&amp;A Class Action Firm Continues Investigating the Merger \u2013 STSA, MYBF, TRTN, CHRA&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-755119","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ALERT: The M&amp;A Class Action Firm Continues Investigating the Merger \u2013 STSA, MYBF, TRTN, CHRA - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/alert-the-ma-class-action-firm-continues-investigating-the-merger-stsa-mybf-trtn-chra\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ALERT: The M&amp;A Class Action Firm Continues Investigating the Merger \u2013 STSA, MYBF, TRTN, CHRA - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, May 04, 2023 (GLOBE NEWSWIRE) &#8212; Juan Monteverde, founder and managing partner of the class action firm Monteverde &amp; Associates PC (the \u201cM&amp;A Class Action Firm\u201d), a national securities firm rated\u00a0Top 50\u00a0in the 2018-2021 ISS Securities Class Action Services Report and headquartered at the\u00a0Empire State Building\u00a0in New York City, is investigating: Satsuma Pharmaceuticals, Inc. (NASDAQ: STSA ), relating to its proposed sale to Shin Nippon Biomedical Laboratories, Ltd. Under the terms of the agreement, STSA Shareholders are expected to receive one non-tradeable CVR of up to $5.77 in cash plus $0.91 in cash per share they own. Click here for more information: https:\/\/www.monteverdelaw.com\/case\/satsuma-pharmaceuticals-inc. It is free and there is no cost or obligation to you. Muncy Bank Financial, &hellip; Continue reading &quot;ALERT: The M&amp;A Class Action Firm Continues Investigating the Merger \u2013 STSA, MYBF, TRTN, CHRA&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/alert-the-ma-class-action-firm-continues-investigating-the-merger-stsa-mybf-trtn-chra\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-05-04T19:57:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMjU1MCM1NTc2Njk3IzIxODQzNTk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alert-the-ma-class-action-firm-continues-investigating-the-merger-stsa-mybf-trtn-chra\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alert-the-ma-class-action-firm-continues-investigating-the-merger-stsa-mybf-trtn-chra\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"ALERT: The M&amp;A Class Action Firm Continues Investigating the Merger \u2013 STSA, MYBF, TRTN, CHRA\",\"datePublished\":\"2023-05-04T19:57:44+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alert-the-ma-class-action-firm-continues-investigating-the-merger-stsa-mybf-trtn-chra\\\/\"},\"wordCount\":594,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alert-the-ma-class-action-firm-continues-investigating-the-merger-stsa-mybf-trtn-chra\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgzMjU1MCM1NTc2Njk3IzIxODQzNTk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alert-the-ma-class-action-firm-continues-investigating-the-merger-stsa-mybf-trtn-chra\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alert-the-ma-class-action-firm-continues-investigating-the-merger-stsa-mybf-trtn-chra\\\/\",\"name\":\"ALERT: The M&amp;A Class Action Firm Continues Investigating the Merger \u2013 STSA, MYBF, TRTN, CHRA - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alert-the-ma-class-action-firm-continues-investigating-the-merger-stsa-mybf-trtn-chra\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alert-the-ma-class-action-firm-continues-investigating-the-merger-stsa-mybf-trtn-chra\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgzMjU1MCM1NTc2Njk3IzIxODQzNTk=\",\"datePublished\":\"2023-05-04T19:57:44+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alert-the-ma-class-action-firm-continues-investigating-the-merger-stsa-mybf-trtn-chra\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alert-the-ma-class-action-firm-continues-investigating-the-merger-stsa-mybf-trtn-chra\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alert-the-ma-class-action-firm-continues-investigating-the-merger-stsa-mybf-trtn-chra\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgzMjU1MCM1NTc2Njk3IzIxODQzNTk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgzMjU1MCM1NTc2Njk3IzIxODQzNTk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alert-the-ma-class-action-firm-continues-investigating-the-merger-stsa-mybf-trtn-chra\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ALERT: The M&amp;A Class Action Firm Continues Investigating the Merger \u2013 STSA, MYBF, TRTN, CHRA\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ALERT: The M&amp;A Class Action Firm Continues Investigating the Merger \u2013 STSA, MYBF, TRTN, CHRA - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/alert-the-ma-class-action-firm-continues-investigating-the-merger-stsa-mybf-trtn-chra\/","og_locale":"en_US","og_type":"article","og_title":"ALERT: The M&amp;A Class Action Firm Continues Investigating the Merger \u2013 STSA, MYBF, TRTN, CHRA - Market Newsdesk","og_description":"NEW YORK, May 04, 2023 (GLOBE NEWSWIRE) &#8212; Juan Monteverde, founder and managing partner of the class action firm Monteverde &amp; Associates PC (the \u201cM&amp;A Class Action Firm\u201d), a national securities firm rated\u00a0Top 50\u00a0in the 2018-2021 ISS Securities Class Action Services Report and headquartered at the\u00a0Empire State Building\u00a0in New York City, is investigating: Satsuma Pharmaceuticals, Inc. (NASDAQ: STSA ), relating to its proposed sale to Shin Nippon Biomedical Laboratories, Ltd. Under the terms of the agreement, STSA Shareholders are expected to receive one non-tradeable CVR of up to $5.77 in cash plus $0.91 in cash per share they own. Click here for more information: https:\/\/www.monteverdelaw.com\/case\/satsuma-pharmaceuticals-inc. It is free and there is no cost or obligation to you. Muncy Bank Financial, &hellip; Continue reading \"ALERT: The M&amp;A Class Action Firm Continues Investigating the Merger \u2013 STSA, MYBF, TRTN, CHRA\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/alert-the-ma-class-action-firm-continues-investigating-the-merger-stsa-mybf-trtn-chra\/","og_site_name":"Market Newsdesk","article_published_time":"2023-05-04T19:57:44+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMjU1MCM1NTc2Njk3IzIxODQzNTk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alert-the-ma-class-action-firm-continues-investigating-the-merger-stsa-mybf-trtn-chra\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alert-the-ma-class-action-firm-continues-investigating-the-merger-stsa-mybf-trtn-chra\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"ALERT: The M&amp;A Class Action Firm Continues Investigating the Merger \u2013 STSA, MYBF, TRTN, CHRA","datePublished":"2023-05-04T19:57:44+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alert-the-ma-class-action-firm-continues-investigating-the-merger-stsa-mybf-trtn-chra\/"},"wordCount":594,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alert-the-ma-class-action-firm-continues-investigating-the-merger-stsa-mybf-trtn-chra\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMjU1MCM1NTc2Njk3IzIxODQzNTk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alert-the-ma-class-action-firm-continues-investigating-the-merger-stsa-mybf-trtn-chra\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/alert-the-ma-class-action-firm-continues-investigating-the-merger-stsa-mybf-trtn-chra\/","name":"ALERT: The M&amp;A Class Action Firm Continues Investigating the Merger \u2013 STSA, MYBF, TRTN, CHRA - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alert-the-ma-class-action-firm-continues-investigating-the-merger-stsa-mybf-trtn-chra\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alert-the-ma-class-action-firm-continues-investigating-the-merger-stsa-mybf-trtn-chra\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMjU1MCM1NTc2Njk3IzIxODQzNTk=","datePublished":"2023-05-04T19:57:44+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alert-the-ma-class-action-firm-continues-investigating-the-merger-stsa-mybf-trtn-chra\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/alert-the-ma-class-action-firm-continues-investigating-the-merger-stsa-mybf-trtn-chra\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alert-the-ma-class-action-firm-continues-investigating-the-merger-stsa-mybf-trtn-chra\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMjU1MCM1NTc2Njk3IzIxODQzNTk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMjU1MCM1NTc2Njk3IzIxODQzNTk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alert-the-ma-class-action-firm-continues-investigating-the-merger-stsa-mybf-trtn-chra\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"ALERT: The M&amp;A Class Action Firm Continues Investigating the Merger \u2013 STSA, MYBF, TRTN, CHRA"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/755119","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=755119"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/755119\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=755119"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=755119"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=755119"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}